Diversified Healthcare Trust – (NASDAQ:DHCNI) Sees Large Decline in Short Interest

Diversified Healthcare Trust – (NASDAQ:DHCNI) was the recipient of a large decrease in short interest during the month of March. As of March 31st, there was short interest totaling 46,246 shares, a decrease of 25.0% from the March 15th total of 61,623 shares. Based on an average daily trading volume, of 39,929 shares, the days-to-cover ratio is currently 1.2 days.

Diversified Healthcare Trust Stock Down 0.5%

Shares of NASDAQ:DHCNI traded down $0.09 on Wednesday, hitting $18.41. The company had a trading volume of 28,199 shares, compared to its average volume of 104,134. Diversified Healthcare Trust has a 52-week low of $12.79 and a 52-week high of $18.50. The business has a 50 day moving average of $17.27 and a 200 day moving average of $17.09.

Diversified Healthcare Trust Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Wednesday, April 15th will be issued a $0.3516 dividend. This represents a $1.41 dividend on an annualized basis and a yield of 7.6%. The ex-dividend date is Wednesday, April 15th.

Diversified Healthcare Trust (NASDAQ: DHCNI) is a publicly traded real estate investment trust (REIT) specializing in healthcare and life science properties. The company’s primary business activities include the acquisition, development, ownership and management of net‐leased medical office buildings, senior housing facilities and life science research and development assets. In addition to property investments, Diversified Healthcare Trust holds mortgage loans and preferred equity interests in the healthcare sector, offering diversified exposure to both real estate and structured financing arrangements.

The company’s portfolio spans a broad range of healthcare asset types, including medical office buildings leased to health systems and physician groups, senior living communities operated by leading care providers, and life science campuses serving biotechnology and pharmaceutical companies.